Application of anti-LRP/LR specific antibodies for the treatment of Alzheimer's disease

Simple item page
dc.contributor.authorJovanovic, Katarina
dc.date.accessioned2014-07-02T12:47:33Z
dc.date.available2014-07-02T12:47:33Z
dc.date.issued2014-07-02
dc.description.abstractAlzheimer’s Disease (AD) is the most prevalent neurodegenerative disease. The candidate aetiological agent for this disease is the 4kDa amyloid beta (Ab) peptide which is derived from the proteolytic cleavage of the amyloid precursor protein (APP) by the b- and g- secretase, respectively. As cellular prion proteins (PrPc) both regulate the cleavage of APP and mediate Ab induced neurotoxicity, a study was undertaken to establish whether the cellular receptor for PrPc, namely the 37kDa/67kDa laminin receptor (LRP/LR) also played a role in AD pathology. Anti LRP/LR specific antibody (IgG1-iS18) blocking LRP/LR resulted in a significant reduction of both Ab and sAPPb levels (the cleavage products of b-secretase), while APP, b- and g-secretase cell surface levels remained unaltered. LRP/LR was found to co-localise with APP, b- and g-secretase both on the cell surface and intracellularly. Furthermore, FRET demonstrated that an interaction existed between presenilin 1 (PS1) of the g-secretase and LRP/LR, while co-immunoprecipitation confirmed that LRP/LR interacted with both b-secretase and PS1. These results indicate that LRP/LR is implicated in the amyloidogenic processing of APP, through an indirect interaction with the b-secretase and a direct interaction with the g-secretase. These findings also suggest the possibility of utilising IgG1-iS18 as a possible therapeutic for the treatment of AD.en_ZA
dc.identifier.urihttp://hdl.handle.net10539/14854
dc.language.isoenen_ZA
dc.subject.lcshAlzheimer's disease.
dc.subject.lcshAlzheimer's disease - Research.
dc.subject.lcshImmunoglobulins.
dc.titleApplication of anti-LRP/LR specific antibodies for the treatment of Alzheimer's diseaseen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Katarina Jovanovic 0605417N PhD Thesis Final Submission.pdf
Size:
11.43 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection